These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3030933)

  • 21. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 22. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of visceral leishmaniasis].
    Tsetentis Y
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():939-41. PubMed ID: 3008683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of allopurinol plus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV.
    Laguna F; López-Vélez R; Soriano V; Montilla P; Alvar J; González-Lahoz JM
    J Infect; 1994 May; 28(3):255-9. PubMed ID: 8089514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fulminant hepatitis in an Italian infant with visceral leishmaniasis.
    di Martino L; Vajro P; Nocerino A; Scotti S; Napolitano G; Vegnente A
    Trans R Soc Trop Med Hyg; 1992; 86(1):34. PubMed ID: 1566298
    [No Abstract]   [Full Text] [Related]  

  • 26. Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
    Wkly Epidemiol Rec; 2017 Sep; 92(35):566-72. PubMed ID: 28945058
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized clinical trial comparing meglumine antimoniate, pentamidine and amphotericin B for the treatment of cutaneous leishmaniasis by Leishmania guyanensis.
    Neves LO; Talhari AC; Gadelha EP; Silva Júnior RM; Guerra JA; Ferreira LC; Talhari S
    An Bras Dermatol; 2011; 86(6):1092-101. PubMed ID: 22281895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 29. Challenges in the management of visceral leishmaniasis.
    Sundar S; Kumar A
    Indian Pediatr; 2005 Jun; 42(6):523-6. PubMed ID: 15995268
    [No Abstract]   [Full Text] [Related]  

  • 30. A 7-month-old girl with fever and bleeding.
    Chaliasos N; Bourantas C; Kritikou E; Lapatsanis P
    Lancet; 1996 Apr; 347(9008):1086. PubMed ID: 8602061
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 32. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral leishmaniasis in paediatrics.
    Kafetzis DA; Maltezou HC
    Curr Opin Infect Dis; 2002 Jun; 15(3):289-94. PubMed ID: 12015464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Mediterranean visceral leishmaniasis.
    Gradoni L; Bryceson A; Desjeux P
    Bull World Health Organ; 1995; 73(2):191-7. PubMed ID: 7743590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of visceral leishmaniasis or kala-azar (author's transl)].
    Laroche R; Sirol J; Poli L
    Med Trop (Mars); 1978; 38(4):401-4. PubMed ID: 215868
    [No Abstract]   [Full Text] [Related]  

  • 36. Anti leishmanial therapy--the changing scene.
    Bichile LS
    J Assoc Physicians India; 1994 Sep; 42(9):682-3. PubMed ID: 7883657
    [No Abstract]   [Full Text] [Related]  

  • 37. [Leishmaniasis caused by Leishmania viannia braziliensis (Lvb). A case of atypical course].
    Costa JM; Vale KC; França F; Lago EL; Magalhães AV; Marsden PD; Sampaio RN
    Rev Soc Bras Med Trop; 1988; 21(2):71-3. PubMed ID: 2854901
    [No Abstract]   [Full Text] [Related]  

  • 38. Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.
    Utili R; Rambaldi A; Tripodi MF; Andreana A
    Infection; 1995; 23(3):182-3. PubMed ID: 7499009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency initiative to reduce leishmaniasis in Afghanistan.
    Querido J
    Lancet Infect Dis; 2004 Oct; 4(10):599. PubMed ID: 15470762
    [No Abstract]   [Full Text] [Related]  

  • 40. Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
    Rodilla F; Magraner J; Aznar J; Orovitg F; Alcácer F; Colomina J; Ferriols F
    Ann Pharmacother; 1994 Nov; 28(11):1305. PubMed ID: 7849352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.